SM

Sonabiti Murmu

Active Director Director DIN 10292131
DIN 10292131 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Sonabiti Murmu

Data last updated:

Sonabiti Murmu is a Director at Cygneev Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Cygneev Pharmaceuticals Private Limited reported revenue of ₹38.7 Lakh (FY 2025).

DIN 10292131
Primary Designation Director
Industry Pharma
First Appointment 24 Aug 2023
Oldest Company Age 3 yrs
Largest company Cygneev Pharmaceuticals Private Limited · ₹38.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Aug 20232023₹38.7 Lakh (FY 2025)Active

Board colleagues of Sonabiti Murmu

NameDINCompanyDesignation
Arpit Saini10292130Cygneev Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cygneev Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sonabiti Murmu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonabiti Murmu

Sonabiti Murmu currently holds 1 directorship: Cygneev Pharmaceuticals Private Limited (Director, since 24 Aug 2023, revenue ₹38.7 Lakh (FY 2025)).

Sonabiti Murmu was first appointed on 24 Aug 2023 as Director at Cygneev Pharmaceuticals Private Limited.

The current boards of Sonabiti Murmu's companies include Arpit Saini (Cygneev Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available